Value-Based Generic Drug Evaluation Focus on Chinese Real-World Evidence
Salvato in:
Autori principali: | Jinmiao Lu (Autore), Xiaohua Ying (Autore), Zhiping Li (Autore) |
---|---|
Natura: | Libro |
Pubblicazione: |
Kerman University of Medical Sciences,
2023-12-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
di: jinmiao Lu, et al.
Pubblicazione: (2023) -
Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases
di: Jinmiao Lu, et al.
Pubblicazione: (2023) -
Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world
di: Jinmiao Lu, et al.
Pubblicazione: (2022) -
First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
di: Jinmiao Lu, et al.
Pubblicazione: (2022) -
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study
di: Finocchietti M, et al.
Pubblicazione: (2024)